Dana S. Hardin

4.6k total citations
73 papers, 3.2k citations indexed

About

Dana S. Hardin is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Dana S. Hardin has authored 73 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 23 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Surgery. Recurrent topics in Dana S. Hardin's work include Cystic Fibrosis Research Advances (26 papers), Diabetes Management and Research (11 papers) and Child Nutrition and Feeding Issues (8 papers). Dana S. Hardin is often cited by papers focused on Cystic Fibrosis Research Advances (26 papers), Diabetes Management and Research (11 papers) and Child Nutrition and Feeding Issues (8 papers). Dana S. Hardin collaborates with scholars based in United States, United Kingdom and France. Dana S. Hardin's co-authors include Dan K. Seilheimer, A. D. Baron, Margaret Johnson, Julie Rice, Kenneth J. Ellis, Jesus H. Dominguez, M. Juhaszova, W. Timothy Garvey, Sarah Elkin and Charles Haworth and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Dana S. Hardin

68 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dana S. Hardin United States 33 1.1k 793 492 480 415 73 3.2k
Massimo Círillo Italy 36 760 0.7× 540 0.7× 614 1.2× 837 1.7× 370 0.9× 195 5.1k
Shana L. Palla United States 33 698 0.6× 520 0.7× 967 2.0× 548 1.1× 421 1.0× 80 4.8k
Y. van der Graaf Netherlands 37 671 0.6× 386 0.5× 208 0.4× 845 1.8× 331 0.8× 84 3.9k
Vittorio Bini Italy 41 1.4k 1.2× 548 0.7× 394 0.8× 1.4k 2.9× 179 0.4× 236 5.0k
Justin Brown United Kingdom 33 806 0.7× 929 1.2× 394 0.8× 618 1.3× 227 0.5× 113 3.6k
Kari Teramo Finland 35 424 0.4× 514 0.6× 382 0.8× 623 1.3× 215 0.5× 123 3.6k
K Schärer Germany 33 812 0.7× 334 0.4× 399 0.8× 464 1.0× 507 1.2× 179 3.9k
Christian Bieglmayer Austria 31 305 0.3× 647 0.8× 289 0.6× 707 1.5× 265 0.6× 109 3.1k
Emanuela Rossi Italy 32 457 0.4× 270 0.3× 423 0.9× 189 0.4× 236 0.6× 127 3.1k
Margaret J. Bia United States 33 1.7k 1.5× 485 0.6× 238 0.5× 934 1.9× 150 0.4× 88 4.4k

Countries citing papers authored by Dana S. Hardin

Since Specialization
Citations

This map shows the geographic impact of Dana S. Hardin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana S. Hardin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana S. Hardin more than expected).

Fields of papers citing papers by Dana S. Hardin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana S. Hardin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana S. Hardin. The network helps show where Dana S. Hardin may publish in the future.

Co-authorship network of co-authors of Dana S. Hardin

This figure shows the co-authorship network connecting the top 25 collaborators of Dana S. Hardin. A scholar is included among the top collaborators of Dana S. Hardin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana S. Hardin. Dana S. Hardin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thakur, Sweta, et al.. (2025). Steps toward clinical validation of exhaled volatile organic compound biomarkers for hypoglycemia in persons with type 1 diabetes. Scientific Reports. 15(1). 18257–18257. 1 indexed citations
2.
Siegel, Amanda P., Ali Daneshkhah, Dana S. Hardin, et al.. (2017). Analyzing breath samples of hypoglycemic events in type 1 diabetes patients: towards developing an alternative to diabetes alert dogs. Journal of Breath Research. 11(2). 26007–26007. 40 indexed citations
3.
Langley, Richard G., Ricardo Romiti, Kristian Reich, et al.. (2016). 053 Evaluation of inflammatory bowel disease in patients with plaque psoriasis studied in phase 3 trials of ixekizumab (UNCOVER Trials): Adjudicated data from the induction period. Journal of Investigative Dermatology. 136(9). S169–S169. 3 indexed citations
4.
Jovanovič, Lois, Anne L. Peters, Honghua Jiang, & Dana S. Hardin. (2013). Durability of glycemic control with insulin lispro mix 75/25 versus insulin glargine for older patients with type 2 diabetes. Aging Clinical and Experimental Research. 26(2). 115–121. 6 indexed citations
5.
Chisolm, Deena J., et al.. (2011). Health Literacy and Willingness to Use Online Health Information by Teens with Asthma and Diabetes. Telemedicine Journal and e-Health. 17(9). 676–682. 38 indexed citations
6.
Hardin, Dana S., et al.. (2009). Use of the insulin pump in treat cystic fibrosis related diabetes. Journal of Cystic Fibrosis. 8(3). 174–178. 49 indexed citations
7.
Rother, Kristina I., Rebecca J. Brown, Miriam M. Morales, et al.. (2009). Effect of Ingested Interferon-α on β-Cell Function in Children With New-Onset Type 1 Diabetes. Diabetes Care. 32(7). 1250–1255. 30 indexed citations
8.
Hardin, Dana S.. (2008). Treatment of short stature and growth hormone deficiency in children with somatotropin (rDNA origin). SHILAP Revista de lepidopterología. 1 indexed citations
9.
Hardin, Dana S., et al.. (2008). Elevated Gluconeogenesis and Lack of Suppression by Insulin Contribute to Cystic Fibrosis-Related Diabetes. Journal of Investigative Medicine. 56(3). 567–573. 25 indexed citations
10.
Burgess, Shawn C., Merrill E. Nuss, Visvanathan Chandramouli, et al.. (2003). Analysis of gluconeogenic pathways in vivo by distribution of in plasma glucose: comparison of nuclear magnetic resonance and mass spectrometry. Analytical Biochemistry. 318(2). 321–324. 32 indexed citations
11.
Brod, Staley A., Mark A. Atkinson, Victor Lavis, et al.. (2001). Ingested IFN- α Preserves Residual β Cell Function in Type 1 Diabetes. Journal of Interferon & Cytokine Research. 21(12). 1021–1030. 20 indexed citations
12.
Hardin, Dana S., et al.. (2001). Growth hormone improves clinical status in prepubertal children with cystic fibrosis: Results of a randomized controlled trial. The Journal of Pediatrics. 139(5). 636–642. 67 indexed citations
13.
Hardin, Dana S., et al.. (2001). Growth Hormone Decreases Protein Catabolism in Children with Cystic Fibrosis. The Journal of Clinical Endocrinology & Metabolism. 86(9). 4424–4428. 41 indexed citations
14.
Hardin, Dana S. & Antoinette Moran. (1999). DIABETES MELLITUS IN CYSTIC FIBROSIS. Endocrinology and Metabolism Clinics of North America. 28(4). 787–800. 43 indexed citations
15.
Hardin, Dana S., et al.. (1999). Increased Leucine Turnover and Insulin Resistance in Men with Advanced HIV Infection. Journal of Investigative Medicine. 47(8). 405–413. 9 indexed citations
16.
Hardin, Dana S.. (1998). The Diagnosis and Management of Cystic Fibrosis Related Diabetes. The Endocrinologist. 8(4). 265–272. 8 indexed citations
17.
Hardin, Dana S. & Judy P. Sy. (1997). Effects of growth hormone treatment in children with cystic fibrosis: The National Cooperative Growth Study experience. The Journal of Pediatrics. 131(1). S65–S69. 51 indexed citations
18.
Hardin, Dana S., Biagio Azzarelli, J Edwards, et al.. (1995). Mechanisms of enhanced insulin sensitivity in endurance-trained athletes: effects on blood flow and differential expression of GLUT 4 in skeletal muscles.. The Journal of Clinical Endocrinology & Metabolism. 80(8). 2437–2446. 86 indexed citations
19.
Hardin, Dana S., Jesus H. Dominguez, & W. Timothy Garvey. (1993). Muscle group-specific regulation of GLUT 4 glucose transporters in control, diabetic, and insulin-treated diabetic rats. Metabolism. 42(10). 1310–1315. 32 indexed citations
20.
Garvey, W. Timothy, Dana S. Hardin, M. Juhaszova, & Jesus H. Dominguez. (1993). Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy. American Journal of Physiology-Heart and Circulatory Physiology. 264(3). H837–H844. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Massimo Círillo Breakdown of academic impact, for papers by Shana L. Palla Breakdown of academic impact, for papers by Y. van der Graaf Breakdown of academic impact, for papers by Vittorio Bini Breakdown of academic impact, for papers by Justin Brown Breakdown of academic impact, for papers by Kari Teramo Breakdown of academic impact, for papers by K Schärer Breakdown of academic impact, for papers by Christian Bieglmayer Breakdown of academic impact, for papers by Emanuela Rossi Breakdown of academic impact, for papers by Margaret J. Bia
Rankless by CCL
2026